Implementation of a System-level Tobacco Treatment Intervention

Completed · Not applicable

Conditions studied: Smoking Cessation, Lung Cancer

In brief

The proposed study plans to adapt and study the implementation and effectiveness of integrating Clinical and Community Effort Against Secondhand smoke Exposure (CEASE) into the thoracic oncology setting using mixed methods.

Key facts

Study ID

NCT02816697

Run by

Dana-Farber Cancer Institute

People needed

263

Starts

2016-06-01

Expected to finish

2026-04-01

Last updated by the study team

2026-04-16

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Age ≥ 18
• Have an actual or potential diagnosis of thoracic malignancy
• Able to read and write in English.
• Current or recent former smoker (defined as having smoked within past 6 months)
• Must have an active telephone number.

You may not qualify if…

• Former smoker greater than 6 months.
• Have any of the below conditions needing immediate medical intervention
• Hypercalcemia causing lethargy and confusion,
• Acute respiratory distress
• Dehydration
• Hypotension

Where it is running

• Brigham and Women's Hospital — Boston, Massachusetts, United States
• Dana Farber Cancer Institute — Boston, Massachusetts, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.